Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3738469010 | Bendroflumethiazide and propranolol only product in oral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3738470011 | Product containing only bendroflumethiazide and propranolol in oral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Bendroflumethiazide and propranolol only product in oral dose form | Has active ingredient | Bendroflumethiazide (substance) | true | Inferred relationship | Some | 2 | |
Bendroflumethiazide and propranolol only product in oral dose form | Is a | Bendroflumethiazide- and propranolol-containing product in oral dose form | true | Inferred relationship | Some | ||
Bendroflumethiazide and propranolol only product in oral dose form | Is a | Bendroflumethiazide and propranolol only product | true | Inferred relationship | Some | ||
Bendroflumethiazide and propranolol only product in oral dose form | Has manufactured dose form | Oral dose form | true | Inferred relationship | Some | ||
Bendroflumethiazide and propranolol only product in oral dose form | Count of base of active ingredient | 2 (kwalificatiewaarde) | false | Inferred relationship | Some | ||
Bendroflumethiazide and propranolol only product in oral dose form | Has active ingredient | Propranolol (substance) | true | Inferred relationship | Some | 1 | |
Bendroflumethiazide and propranolol only product in oral dose form | Plays role | Diuretic therapeutic role | false | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule | Is a | True | Bendroflumethiazide and propranolol only product in oral dose form | Inferred relationship | Some | |
Product containing precisely bendroflumethiazide 2.5 milligram and propranolol hydrochloride 80 milligram/1 each conventional release oral capsule (clinical drug) | Is a | True | Bendroflumethiazide and propranolol only product in oral dose form | Inferred relationship | Some |
This concept is not in any reference sets